List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 946 studies with search of: "Merck" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain
Condition: Postoperative Pain
Interventions: Drug: MK0966, rofecoxib;   Drug: Comparator: valdecoxib
2 Recruiting Lipid Efficacy and Safety in Patients With Mixed Hyperlipidemia
Condition: Mixed Hyperlipemia
Interventions: Drug: MK0524B;   Drug: Atorvastatin
3 Recruiting Dose Range Finding Study of MK0941 in Patients With Type 2 Diabetes on Insulin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Comparator: MK0941;   Drug: Comparator: Placebo
4 Recruiting Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast
Condition: Asthma
Interventions: Drug: montelukast sodium;   Drug: Comparator: placebo comparator
5 Completed A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension
Condition: Hypertension
Interventions: Drug: losartan potassium;   Drug: Comparator: placebo
6 Terminated An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: vorinostat;   Drug: Comparator: bexarotene
7 Active, not recruiting C-PHONE Study
Condition: Chemotherapy Induced Nausea and Vomiting
Intervention: Behavioral: Disease Management Assessment
8 Completed A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol
Condition: Cholesterol
Interventions: Drug: ezetimibe;   Drug: Comparator: Placebo (unspecified);   Drug: simvastatin
9 Completed A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MK1006;   Drug: Comparator: Placebo
10 Completed MK0524 Asthma POC Study
Condition: Asthma
Interventions: Drug: Comparator: MK0524 + placebo;   Drug: Comparator: MK0524 + montelukast;   Drug: Comparator: placebo + montelukast;   Drug: Comparator: Placebo
11 Completed BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs
Condition: Dementia
Interventions: Drug: MK3134;   Drug: Comparator: Placebo;   Drug: Donepezil;   Drug: MK3134
12 Completed Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: MK0431, sitagliptin phosphate / Duration of Treatment: 18 weeks
13 Recruiting Suberoylanilide Hydroxamic Acid (SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma;   Lung Cancer
Interventions: Drug: Comparator: Suberoylanilide Hydroxamic Acid (SAHA);   Drug: Comparator: Placebo
14 Completed A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)
Conditions: Breast Cancer;   Metastatic Bone Disease
Interventions: Drug: Odanacatib;   Drug: Comparator: zoledronic acid;   Drug: Comparator: Placebo (unspecified);   Drug: Comparator: Placebo (unspecified)
15 Completed A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-Abdominal Infections in Adults
Condition: Intra-Abdominal Infection
Interventions: Drug: Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks;   Drug: MK0826, /Duration of Treatment : 8 Weeks;   Drug: Comparator: metronidazole / Duration of Treatment: 8 Weeks
16 Recruiting MK4827 in Patients With Advanced Solid Tumors and BRCA Mutant Ovarian Cancer
Conditions: Solid Tumors and Ovarian Neoplasms;   Ovarian Neoplasms
Intervention: Drug: Comparator: MK4827 (PARP inhibitor)
17 Completed Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis
Condition: Osteoarthritis
Interventions: Drug: MK0663, etoricoxib;   Drug: Comparator: Diclofenac sodium
18 Terminated Vytorin Treating Uncontrolled Lipids (VyTUL) Study
Conditions: Cardiovascular Diseases;   Diabetes Mellitus
Interventions: Drug: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks;   Drug: Comparator: atorvastatin / Duration of Treatment: 6 Weeks
19 Active, not recruiting MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen - Study A
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: Comparator : lopinavir (+) ritonavir;   Drug: Comparator: placebo (unspecified);   Drug: Comparator: placebo (unspecified)
20 Withdrawn A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension
Condition: Hypertension
Interventions: Drug: hydrochlorothiazide (+) losartan potassium;   Drug: losartan potassium;   Drug: Comparator: losartan potassium;   Drug: Comparator: Placebo (unspecified);   Drug: Comparator: Placebo (unspecified)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services